Key takeaway
Contrast-enhanced mammography (CEM) combines conventional mammographic anatomy with iodine-enhancement information. Its value comes from seeing both structural abnormalities and contrast uptake. Safe examinations require appropriate patient selection, contrast screening, accurate positioning, careful timing, and interpretation of both image sets. [1]
Imagine examining dense breast tissue and finding an area that is difficult to distinguish from the surrounding structures. Conventional mammography may show an overlapping density without clearly establishing its significance. What if a second image could highlight areas of iodine uptake and provide additional clues?
That is the principle behind contrast-enhanced mammography, an increasingly important technique in breast imaging. For radiologic technologists, it introduces additional knowledge requirements involving intravenous contrast, dual-energy X-ray acquisition, radiation safety, and image-quality assessment.
The Canadian Association of Radiologists (CAR) published updated CEM practice guidelines in May 2026. These describe its expanding role in diagnostic problem-solving, preoperative assessment, selected screening situations, and image-guided procedures. [1]
1. What Is Contrast-Enhanced Mammography?
Contrast-enhanced mammography is a breast-imaging examination performed using a digital mammography system equipped for dual-energy acquisition. An iodinated contrast agent is injected intravenously before the mammographic images are obtained.
The system produces two complementary image sets:
- Low-energy (LE) images: Provide anatomical information comparable to standard digital mammography, including masses, calcifications, asymmetries, and architectural distortion.
- Recombined (RC) images: Use information from paired low- and high-energy exposures to emphasize iodine enhancement while suppressing much of the background breast-tissue signal.
These image sets are interpreted together. Recombined images do not replace conventional mammographic assessment, because some suspicious findings may show little or no enhancement. [1]
Why does iodine enhancement matter?
Malignant breast lesions may develop abnormal blood vessels through angiogenesis. Contrast enhancement can reflect vascular supply and tissue permeability, providing information that is different from the appearance of anatomical structures alone.
However, enhancement is not specific to cancer. Benign lesions and physiological background tissue may also enhance. Conversely, the absence of enhancement does not exclude malignancy. Findings must be correlated with their morphology, clinical context, and other examinations.
2. How Does Dual-Energy CEM Work?
Conventional mammography uses X-ray attenuation differences to form an anatomical image. CEM adds a method of separating the iodine-related signal from surrounding tissues by using two X-ray energy ranges.
The 2026 CAR guideline describes paired low-energy exposures in the approximate range of 23–32 kVp and high-energy exposures at approximately 45–49 kVp. These are guideline-described operating ranges, not universal settings for every mammography system. [1]
Because iodine affects the X-ray signal differently across the energy ranges, software can combine the paired acquisitions to emphasize iodine-containing regions. This produces the recombined image that highlights enhancement.
3. When Is Contrast-Enhanced Mammography Used?
CEM is primarily a diagnostic technique. Its additional enhancement information can be helpful when conventional anatomical imaging leaves an unanswered clinical question.
According to the 2026 CAR guidelines, potential applications include:
- Diagnostic problem-solving: Further evaluation of selected abnormalities detected on screening or diagnostic mammography.
- Dense breast assessment: Additional diagnostic information where overlapping dense tissue makes lesion identification difficult.
- Preoperative evaluation: Assessing the extent of known malignancy and investigating additional findings.
- Treatment monitoring: Evaluating selected patients during or after systemic therapy.
- Selected supplemental screening: An alternative in certain situations when breast MRI is unavailable or cannot be tolerated.
- Interventional guidance: Localizing or sampling selected enhancing abnormalities.
These are potential indications, not a recommendation that every patient should undergo CEM. The supervising radiologist determines whether its benefits outweigh the risks for the individual clinical scenario. [1]
Does CEM replace breast MRI?
No. MRI remains the preferred supplemental breast-screening modality for many high-risk populations. CAR specifically cautions against routinely substituting CEM for MRI in high-risk screening, particularly for patients with BRCA-associated hereditary risk. [1]
CEM may be considered when an appropriate MRI examination is inaccessible, contraindicated, or not tolerated, depending on the clinical circumstances and regional breast-imaging pathway.
4. Patient Screening and Iodinated Contrast Safety
One major difference between conventional mammography and CEM is the use of an intravenous iodinated contrast agent. This introduces safety requirements familiar to contrast-enhanced CT departments.
Screening for contrast-related risks
Before an examination, appropriately trained personnel must assess relevant clinical history according to institutional policy.
- Previous contrast reactions: Determine the specific agent, reaction characteristics, severity, and any documented management plan.
- Kidney function: Identify patients with acute kidney injury or relevant kidney risk factors who require assessment under current contrast guidelines.
- Pregnancy considerations: Escalate possible pregnancy and the clinical necessity of imaging to the supervising clinician.
- Intravenous access: Confirm suitable access and monitor for discomfort or evidence of extravasation during injection.
- Emergency preparedness: Ensure that trained clinical personnel and required emergency equipment are available.
CAR identifies severe underlying chronic kidney disease and acute kidney injury as important considerations when evaluating the risk of contrast-associated kidney injury. However, a kidney-function result should not be interpreted as an automatic universal decision to cancel an examination. Risk assessment and the final decision belong to the responsible clinical team. [1]
For detailed management recommendations, consult the ACR Manual on Contrast Media. [3]
5. Contrast Timing, Acquisition, and a Worked Calculation
CEM combines the need for precise breast positioning with the additional timing requirements of contrast-enhanced imaging. A technically adequate image may still provide suboptimal enhancement information if the acquisition is poorly coordinated.
The imaging sequence
The 2026 CAR guideline describes an examination beginning with intravenous low-osmolar, nonionic iodinated contrast. Imaging starts after an appropriate uptake interval, with paired low- and high-energy acquisitions obtained for the required projections.
CAR describes beginning breast compression approximately two minutes after the start of contrast injection and completing the primary image-acquisition sequence within seven minutes of administration. Additional images may be obtained when indicated. These timings must be interpreted within the approved local protocol. [1]
The standard craniocaudal (CC) and mediolateral oblique (MLO) projections remain central to the examination. Positioning must demonstrate the required anatomy while maintaining patient comfort and acquisition efficiency.
Worked calculation: understanding contrast volume
The CAR guideline describes a standard weight-based contrast-volume approach of 1.5 mL/kg, using iodinated contrast concentrations of approximately 300–370 mg iodine/mL. [1]
Educational calculation
Consider a hypothetical adult weighing 60 kg, using the guideline-described 1.5 mL/kg factor and a 300 mg iodine/mL preparation.
Step 1 — Calculate contrast volume:
60 kg × 1.5 mL/kg = 90 mL
Step 2 — Calculate total iodine mass:
90 mL × 300 mg iodine/mL = 27,000 mg iodine
27,000 mg ÷ 1,000 = 27 g iodine
Interpretation: The example illustrates the relationship between patient weight, contrast volume, and iodine concentration. It is not a patient-specific contrast order.
Real examinations require confirmation of the prescribed agent, institutional volume limits, patient-specific contraindications, injection parameters, and the supervising clinician's instructions. Technologists must not calculate and administer contrast independently outside their authorized scope of practice.
6. Radiation Dose, Image Quality, and CEM Artifacts
CEM involves ionizing radiation because paired X-ray exposures are acquired for each dual-energy view. Its additional high-energy acquisition increases radiation exposure compared with conventional mammography.
The 2026 CAR guideline describes CEM radiation exposure as approximately 30% higher than digital mammography and digital breast tomosynthesis, while remaining within the range encountered in other common mammographic examinations. This is a generalized guideline comparison, not a dose prediction for an individual patient. [1]
The same guideline specifies an average glandular dose limit of 3 mGy for a craniocaudal projection under its described CEM requirements. Actual dose management must follow equipment specifications, applicable accreditation requirements, and medical-physics oversight. [1]
Common technical problems
Because CEM depends on paired images and software recombination, technologists must recognize artifacts that may not be encountered in routine digital mammography.
- Motion or misregistration: Movement between paired exposures can produce subtraction artifacts.
- Skin folds and trapped air: May interfere with image recombination or create misleading appearances.
- Incorrect acquisition timing: Can reduce the diagnostic usefulness of contrast-enhancement information.
- Inadequate positioning: May exclude clinically important tissue or prevent a reliable examination.
- Implant-related limitations: Silicone implants can interfere with recombination. The CAR guideline recommends appropriate implant-displacement views and cautions against CEM when adequate compression or displacement cannot be achieved.
Repeat exposures should never be performed reflexively. When an artifact is identified, assess whether it compromises the required information and follow approved escalation and repeat-image policies. [1]
7. CEM vs Standard Mammography vs Breast MRI
Understanding where CEM fits among existing breast-imaging techniques helps radiographers explain examinations accurately without overstating their diagnostic capabilities.
| Feature | Digital Mammography | CEM | Contrast-Enhanced Breast MRI |
|---|---|---|---|
| Imaging principle | X-ray attenuation | Dual-energy X-rays with iodine enhancement | Magnetic resonance with contrast enhancement |
| Intravenous contrast | No | Iodinated contrast | Usually gadolinium-based contrast |
| Ionizing radiation | Yes | Yes | No |
| Breast compression | Yes | Yes | No mammographic compression |
| Enhancement information | No intravenous enhancement assessment | Yes | Yes |
| Clinical role | Established screening and diagnostic technique | Selected diagnostic and supplemental examinations | High-risk supplemental screening and selected diagnostic examinations |
What does comparative research show?
A 2022 systematic review and meta-analysis published in Radiology compared CEM with contrast-enhanced breast MRI across seven studies involving 1,137 lesions.
The researchers reported pooled sensitivity of 91% for CEM and 97% for contrast-enhanced MRI. Pooled specificity was 74% for CEM and 69% for MRI; the specificity difference was not statistically significant. [2]
These findings require careful interpretation. The studies involved selected populations with a high proportion of malignancies, and between-study heterogeneity was substantial. The percentages should not be presented as universal detection rates for routine population screening.
In the studied setting, MRI demonstrated higher sensitivity. However, examination selection also involves accessibility, contraindications, the need for biopsy, patient preferences, and the particular diagnostic question. [2]
The Technologist's Role in a Successful CEM Examination
While the radiologist establishes the clinical indication and interpretation, the technologist plays a central role in obtaining usable images and safeguarding the patient.
Practical responsibilities include verifying the correct examination and patient identity, completing the required safety checks, confirming the approved contrast plan, achieving accurate positioning, observing acquisition timing, monitoring patient comfort, and recognizing image-quality problems.
Quality assurance also extends beyond the individual examination. The CAR guideline assigns technologists specific CEM quality-control responsibilities and requires medical-physics oversight of the dual-energy imaging system. [1]
One essential principle is that a suspicious abnormality on the low-energy mammogram must not be dismissed merely because it fails to enhance on the recombined image. The two image sets provide complementary information, and both remain important for diagnostic assessment.
The American College of Radiology's BI-RADS v2025 manual includes a dedicated contrast-enhanced mammography section to support standardized reporting and communication. [4]
Quick Knowledge Check
Question: What is the main purpose of the recombined image in contrast-enhanced mammography?
Correct answer: B
Recombined CEM images emphasize iodine-related enhancement. They do not replace low-energy anatomical images, which remain necessary for evaluating masses, distortion, calcifications, and other abnormalities. [1]
Key Takeaways
- CEM combines conventional mammographic anatomy with functional iodine-enhancement information.
- Dual-energy acquisition generates complementary low-energy and recombined image sets.
- Patient screening and contrast safety are essential parts of the examination.
- Accurate positioning, injection coordination, and acquisition timing influence image quality.
- CEM adds radiation exposure and requires appropriate dose management and quality control.
- Breast MRI remains important, particularly in high-risk supplemental screening.
- Technologists should never assume that the absence of enhancement excludes a suspicious abnormality.
Learn More on Radiography101
- Mammography Positioning and Compression
- Contrast Media in Radiology
- Contrast Extravasation: Recognition and Management
- Radiation Dose Units Explained
- Radiography Practice Test Center
Authoritative Sources
- Crivellaro PS, Fienberg S, Flegg C, et al. CAR Practice Guidelines on Breast Imaging and Interventions: Contrast-Enhanced Mammography. Canadian Association of Radiologists Journal. Published online May 26, 2026. https://doi.org/10.1177/08465371261451253 . Primary Canadian professional guidance for indications, imaging technique, contrast administration, safety, and quality control.
- Pötsch N, Vatteroni G, Clauser P, Helbich TH, Baltzer PAT. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis. Radiology. 2022;305(1):94–103. https://doi.org/10.1148/radiol.212530 . Comparative evidence on diagnostic sensitivity, specificity, and study limitations.
- American College of Radiology. ACR Manual on Contrast Media. Official professional resource. ACR Contrast Manual . Reference for contrast-agent safety, patient screening, reactions, renal considerations, and administration practices.
- American College of Radiology. ACR BI-RADS v2025 Manual — Contrast Enhanced Mammography. Reston, VA: American College of Radiology; 2025. ACR BI-RADS resources . Official standardized reporting and terminology resource.